Twenty-four-hour intravenous and oral tracer studies with L-[1-13C]-2-aminoadipic acid and L-[1-13C]lysine as tracers at generous nitrogen and lysine intakes in healthy adults

Background: This is a continuation of investigations of the relations between amino acid kinetics and amino acid dietary requirements in healthy adults. Objective: The aim was to investigate the 24-h pattern and rate of the metabolism of an L-[1-C-13]-2-aminoadipic acid ([C-13]AAA) tracer and of whole-body L-[1-C-13]lysine ([C-13]lysine) oxidation and balance in healthy, young adults receiving a generous intake of lysine. Design: Thirteen healthy adults were given an adequate, L-amino acid-based diet supplying 77 mg lysine.kg(-1).d(-1) for 6 d before the tracer studies. Two subjects received [C-13]AAA intravenously and 2 received it orally; 3 subjects received [C-13]lysine intravenously and 6 received it orally. We measured (CO2)-C-13 output, plasma [C-13]AAA and [C-13]lysine enrichment, and urinary [C-13]AAA. Results: [C-13]AAA oxidation was estimated to be higher after the orally administered than after the intravenously administer tracer; plasma [C-13]AAA was similar to urinary [C-13]AAA. Whole-body lysine oxidation showed a rhythm that was induced by meal feeding. The intravenous [C-13]lysine tracer gave mean estimates of lysine balances (lysine intake minus oxidation) that apparently were too low (-15.7 mg.kg(-1).d(-1)) or too high (16.6 mg.kg(-1).d(-1), P < 0.05 from zero balance) on the basis of urinary [C-13]AAA or plasma [C-13]lysine estimates of oxidation, respectively. For the orally administered tracer and plasma [C-13]lysine enrichment, the mean balance was slightly positive (8.7 mg.kg(-1).d(-1), P < 0.05 from zero). Conclusions: Use of urinary [C-13]AAA as an index of the enrichment of the precursor pool did not appear to significantly improve the estimate of the fasting and feeding components of daily lysine balance. For estimates of daily, whole-body lysine oxidation, we propose use of plasma [C-13]lysine with a 24-h, orally administered tracer protocol.